NCT00238459View on ClinicalTrials.gov

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised

CompletedOBSERVATIONAL
Enrollment

58

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

March 31, 2011

Study Completion Date

October 31, 2013

Conditions
HIV Infections
Interventions
DRUG

Patients elected to take licensed drugs. The vaccine was not provided for evaluation

Note:In August 2007 we were notified by the manufacturer that the experimental vaccine was no longer being made and would no longer be available for this study. Too few participants have received the vaccine or placebo to conclude anything about potential efficacy

DRUG

multiple licensed drugs not randomized

DRUG

multiple licensed antiretroviral drugs; not randomized

OTHER

Intended vaccine not provided, Licensed drugs provided, but were not investigated

Trial Locations (2)

10016

New York University School of Medicine, New York

Unknown

McGill University and University of Montreal, Montreal

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00238459 - Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised | Biotech Hunter | Biotech Hunter